ING THINK
Japan: Asia’s Europe?
From the original
ASIA/PACIFIC: Japan mirrors Europe’s pharma challenge: it is an important biopharmaceutical innovation market historically. However, in recent years its share of global drug approvals and clinical trials has declined. An ageing population, limited capital markets depth, conservat
Related speeches
4 itemsING THINKMay 27, 2026
China’s spectacular rise reshapes Asia’s pharma future
DESK NOTEING EconomicsMay 27, 2026
China’s spectacular rise reshapes Asia’s pharma future
ING THINKMay 27, 2026
India: from generics giant to innovation powerhouse?
GOOGLE NEWS · USD/JPYNov 5, 2025
Japan: Leading the pack but behind the curve - J.P. Morgan Private Bank
Japan's economic trajectory is observed to be leading in certain areas, as noted by J.P. Morgan. However, this leadership is juxtaposed against a backdrop of monetary policy lagging compared to its global counterparts, raising questions about sustainability and competitiveness.
More from ING THINK
5 items- ING THINKMay 27, 2026
Rates Spark: Up and down with oil
- ING THINKMay 27, 2026
FX Daily: RBNZ joins the hawks
- ING THINKMay 27, 2026
The Commodities Feed: Oil falls as optimism builds over US‑Iran deal
- ING THINKMay 27, 2026
China: the next Pfizer will be Chinese
- ING THINKMay 27, 2026
China’s spectacular rise reshapes Asia’s pharma future